AW: OCPs

From: Pasqualetti Roberto KSSG_FRA (foa4@ms1.kssg.ch)
Thu Aug 27 05:57:19 1998


OCP (0.15 mg desogestrel / 0.03 mg ethynilestradiol)

R. Pasqualetti MD Kantonsspital St. Gallen Switzerland

>----------
>Von: Braun, R. Daniel[SMTP:rbraun@iupui.edu]
>Gesendet: Donnerstag, 27. August 1998 12:52
>An: Multiple recipients of list
>Betreff: RE: OCPs
>
>Who or what is "Marvelon"?
>Dan
>
> -----Original Message-----
> From: john.robertson@obgyn.net [SMTP:john.robertson@obgyn.net]
> Sent: Wednesday, August 26, 1998 5:22 PM
> To: Multiple recipients of list
> Subject: Gyn: OCPs
>
> Read a recent article talking about OCPs and DVT - a hot topic
>in Quebec
> right now because of a law suit there. One of the points made
>was the
> need to discuss discontinuation of OCPs prior to surgery. Was
>wondering
> how the list members handle this issue? In a related "vein",
>recently I
> have had questions asked about Marvelon, whose reputation I
>thought had
> been redeemed - any comments?
>
> John
>
> --
> J.G.M.Robertson MD, 109-9181 Main St. Chilliwack, B.C. V2P 4M9
> (604) 793-9988 e-mail john.robertson@obgyn.net
> Who is wise and understanding among you? Let him show it by his
>good life,
> by deeds done in the humility that comes from wisdom. James 3
>vs 13, NIV
>





use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Mon Nov 2 05:28:35 2009

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.